Phase II clinical and pharmacokinetic (PK) trial of zalypsis (Z) in patients with urothelial carcinoma (UC) progressing after a first-line platinum-based regimen.
Ismael Ghanem
No relevant relationships to disclose
Joan Carles
No relevant relationships to disclose
Joaquim Bellmunt Molins
No relevant relationships to disclose
Cinthya Coronado
Employment or Leadership Position - PharmaMar
Stock Ownership - PharmaMar
José Pablo Maroto
No relevant relationships to disclose
Albert Font Pous
No relevant relationships to disclose
Rafael Morales
No relevant relationships to disclose
Cristina Suarez
No relevant relationships to disclose
Olatz Etxaniz
No relevant relationships to disclose
Laia Capdevila
No relevant relationships to disclose
Cristina Martin Lorente
No relevant relationships to disclose
Cleofe Rodriguez
No relevant relationships to disclose
Carmen Maria Kahatt
No relevant relationships to disclose
Manuel Luque
Employment or Leadership Position - PharmaMar
Stock Ownership - PharmaMar
Daniel E. Castellano
No relevant relationships to disclose